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Abstract.  The rho proteins,  p21 ~,  are ubiquitously 
expressed guanine  nucleotide binding proteins  with 
,'o30%  amino acid homology to p21'%  but their bio- 
chemical  function is unknown.  We show here that mi- 
croinjection  of constitutively activated recombinant  rho 
protein  (Vall4rho)  into  subconfluent cells induces dra- 
matic changes in cell morphology:  15-30 min after in- 
jection cells adopt a distinct  and novel phenotype with 
a  contracted  cell body and finger-like processes  still 
adherent to the substratum.  Ribosylation of Vall4rho 
with the ADP-ribosyltransferase  C3  from clostridium 
botulinum, before microinjection,  renders the protein 
biologically inactive,  but it has  no effect on either its 
intrinsic  biochemical properties  or on its interaction 
with the GTPase activating protein,  rho GAP.  Micro- 
injection of ribosylated normal  rho,  on the other hand, 
has a  similar effect to injection of C3 transferase  and 
induces complete rounding  up of cells.  We also report 
striking  biochemical  changes  in actin  filament organi- 
zation when contact-inhibited  quiescent  3T3 cells are 
injected with Vall4rho protein.  The effects induced by 
activation  or inactivation  of p21 ~  described here,  sug- 
gest that the biological function  of this protein  is to 
control  some aspect of cytoskeletal organization. 
T 
HE guanine  nucleotide binding  proteins,  p21 =~ have 
attracted a great deal of attention since they appear to 
be  regulatory  components  of  the  proliferative  re- 
sponse (Barbacid,  1987;  Morris et al.,  1989).  However, it 
is now evident that the three ras proteins are members of a 
much  larger  superfamily  of  related  proteins  (Chardin, 
1988). Six proteins, rapl (A and B), rap2, R-ras, and ral (A 
and B) have ~50%  amino acid homology to ras and there 
is evidence that some of these may also be involved in the 
control of cell proliferation (Pizon et al.,  1988; Lowe et al., 
1987;  Kitayama et al.,  1989; Garrett et al.,  1989). A large 
subgroup of ras-related proteins, rab, have less homology to 
ras  (30%)  and almost nothing  is known of their function, 
though two S. cerevisiae proteins, YPT1 and SEC4, that be- 
long to this group are involved in intracellular vesicle trans- 
port (Zahraoui et al.,  1989; Segev et al., 1988; Salmien and 
Novick,  1987).  The three mammalian  rho proteins (A, B, 
and C) are "030% homologous to ras and are ubiquitously 
expressed (Madaule and Axel, 1985; Yeramian et al.,  1987; 
Olofsson et al.,  1988).  Based on the resemblance of their 
carboxy termini to ras, they are presumed to function at the 
plasma membrane (Hancock et al., 1989), though significant 
amounts of rho can be found in cytoplasm (Narumiya et al., 
1988). The RHO1 gene of S. cerevisiae is closely related to 
mammalian  rho  and  deletion  of the  yeast gene  is  lethal 
(Madaule  et al.,  1987).  It has  been shown that  an  ADP- 
ribosyltransferase  from  clostridium  botulinum,  C3,  can 
ribosylate rho on asparagine 41 (Narumiya et al., 1988; Ak- 
tories et al., 1989; Sekine et al., 1989), and that introduction 
of C3 into cells induces rounding up and the dissolution of 
actin  microfilaments  (Rubin  et al.,  1988;  Chardin  et al., 
1989;).  However, two additional  C3  substrates,  racl  and 
rac2, have recently been identified (Didsbury et al.,  1989), 
and the role of rho in the C3-induced effects is unclear. 
We have previously reported  the purification  of recom- 
binant rho protein from an E. coli expression system (Garrett 
et al., 1989). The intrinsic biochemical properties of the pro- 
tein were similar to those previously described for ras; i.e., 
a  slow,  Mg2+-dependent,  guanine nucleotide exchange rate 
and a  slow intrinsic  GTP hydrolysis rate.  In addition,  we 
identified a 29-kD GTPase activating protein, rho GAP, that 
could stimulate the intrinsic GTPase activity of rho. Muta- 
tion of glycine to valine at codon 14 of rho had similar bio- 
chemical consequences to oncogenic codon  12 changes in 
ras;  namely,  it reduced the  intrinsic  GTPase activity and 
blocked rho GAP-stimulated GTP hydrolysis (Garrett et al., 
1989). We reasoned that as with ras,  the biological effects 
of a Vall4rho protein should represent those of a constitu- 
tively activated protein. We have, therefore, made use of the 
microinjection  technique  to  examine  both  the  biological 
function of rho and the effect of ribosylation on its biological 
and biochemical activities. 
Materials and Methods 
Expression and Purification of rho Protein 
Normal and mutant rhoA cDNAs were expressed under the control of the 
tryptophan promoter in E.  coli as described earlier (Garrett et al.,  1989). 
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carboxy terminal region. However, we serendipitously observed that pro- 
tein derived from a eDNA clone with a hpa I site engineered at codon 25 
(and as a  consequence having a  Phe--*Asn amino acid substitution) was 
largely full length and very little clipping was observed. The recombinant 
protein obtained using this vector has a similar intrinsic GTPase activity 
to nonmutated rho protein and responds normally to rho GAP stimulation. 
We have used this eDNA expression vector throughout this work. Sonicated 
extracts  were  chromatographed  over  a  DEAE-Sephacel  ion-exchange 
column and through a G75 Sephadex gel filtration column as described pre- 
viously in the purification of ras proteins (Hall and Self, 1986). The protein 
was judged to be ~30% pure by Coomassie blue staining after electrophore- 
sis on polyacrylamide gels and ~0.5 mg of rho protein was obtained from 
4 liters of culture. The protein was concentrated to 0.5 nag Vall4rho/ml or 
5 nag normal rho/mi, sterilized by filtration, and snap-frozen in liquid nitro- 
gen. Mutagenesis of Ash to lie at codon 41 was carried out by site-directed 
mutagenesis using a mutagenesis kit (Amersham International, Amersham, 
UK). Mutant cDNAs were completely sequenced before being reintroduced 
into the E.  coli expression plasmid. 
Microinjection of rho eDNA in a Mammalian 
Expression Vector 
Normal and activated (Vail4) rho cDNAs were introduced into the eukary- 
otic expression vector pEXV (Hancock et al.,  1989). These cDNAs lacked 
the Phe~Asn  substitution used to  stabilize recombinant protein in our 
E.  coli expression system. DNA expression from pEXV is under the control 
of the SV40 early region promoter and enhancer. Plasmid DNA (0.1 #g/mi) 
was microinjected into the nuclei of subconfluent cells and its effects on in- 
dividual cells observed over 48 h using time-lapse video recordings. 
Ribosylation of  rho Proteins 
C3  transferase  from  Clostridium  botulinum  type  C3  was  purified  to 
homogeneity and concentrated to 0.3 mg/ml as described previously (Akto- 
ries et al.,  1988). Titration of C3 by microinjection revealed that >3 #g/mi 
was required for efficient rounding up of cells. For microinjection, rho pro- 
teins were incubated with C3 transferase as follows:  10 mM Tris-HCl, pH 
7.4, 0.1 mM GTP, 50 mM NaC1,  rho (5 #g) C3 transferase (3 ng) in a vol- 
ume of 10 #1. Ribosylation was initiated by addition of 0.5 mM NAD (in 
the absence of NAD no ribosylation occurred) and the mixture was left for 
60 min at 37"C. The mixture was then directly injected into Swiss-3T3 cells. 
For gel electrophoresis, rho proteins (50 #g/ml) were ribosylated by incuba- 
tion with 132P]NAD (0.5 #Ci, 2  mCi/mi) and C3 transferase (0.75 #g/ml) 
for 1 h at 37°C in 50 mM Tris, pH 7.5, 2 mM MgCl2, 0.3 mM GTE Pro- 
tein was precipitated with 30 % trichloroacetic acid and ribosylated proteins 
observed after PAGE and autoradiography as described previously (Akto- 
ries et al.,  1988). Western blots were developed using as the first antibody 
a rabbit polyclonai antibody raised against a synthetic peptide correspond- 
ing to amino acids 65-75 of mammalian rhoA.  To analyze the effects of 
ribosylation  on  the  biochemical  properties  of  rho,  the  protein  was 
ribosylated as described above except nonradioactive NAD was used at 0.2 
mM.  The ribosylated protein was preincubated with ['y-32p]GTP and the 
intrinsic and rho GAP-stimulated GTPase activities were determined by 
measuring the loss of bound counts in a filter binding assay as described 
previously (Garrett et al., 1989). To test the extent of ribosylation a parallel 
ribosylation  reaction  was  set  up  containing  in  addition  [32PlNAD  (0.7 
#Ci).  This  parallel  reaction  was  collected  onto  nitrocellulose  filters, 
washed, and the extent of labeling determined by scintillation counting. The 
amount  of rho present in the  incubation mixture  was  determined  by  a 
[3H]GTP  binding assay  (Hall  and Self,  1986) and a  comparison of the 
GTP binding assay and the amount of 32p incorporated after ribosylation 
revealed that 40-50%  of the protein was ribosylated. 
Fluorescent Labeling of Cytoskeletal Proteins 
Cells  cultured  on marked  areas  of glass  coverslips  were  microinjected 
cytoplasmically with 0.5 mg/ml Va114rho. 3 h after injection cells were fixed 
and processed as follows: for actin, cells were fixed in 3% paraformalde- 
hyde,  permeabilized in 0.2%  Triton X-100,  and incubated with TRITC- 
Phalloidin (Sigma Chemical Co., St. Louis, MO) for 30 rain. For tubulin 
and vimentin,  cells were  fixed in acetone/methanol and incubated with 
mouse  anti-/~-tubulin  (Amersham  International)  or  goat  antivimentin 
(Sigma Chemical Co.) primary antibodies, followed by appropriate FITC- 
conjugated  second  antibodies.  Images  were  recorded  using  a  Bio-Rad 
MRC500 confocal microscope. 
Results 
Microinjection of  Activated rho Protein 
Normal and mutant rhoA cDNAs were expressed under the 
control of the tryptophan promoter in E. coli as described 
previously (Garrett et al.,  1989).  Approximately 0.5 mg of 
rho protein was obtained from 4 L of culture and judged to 
be around 30%  pure.  Vall4rho protein was microinjected 
into subconfluent Swiss 3T3 cells and its effects on individual 
cells were observed using time-lapse video recordings over 
a period of 2 d. Fig. 1, a and b shows that at concentrations 
of rho protein >0.3 mg/ml and beginning ,o15 min after in- 
jection, dramatic changes are induced in the cells' morphol- 
ogy. The cells contract but leave parallel finger-like cytoplas- 
mic processes still adherent to the substratum, resulting in 
the unusual but characteristic phenotype shown in Fig.  1 b 
(rho phenotype). After 10-20 h, most injected cells begin to 
detach and die. Any cells still attached after ,02 d regain 
their normal phenotype after degradation of  injected protein. 
If confluent cells are injected, changes in cell shape are less 
dramatic though still apparent and the cells do not detach. 
After ,02 d  all injected cells regain their normal cellular 
morphology. These effects are quite distinct from those seen 
after injecting Va112 ras (at 0.5 mg/ml). Fig.  1 c shows the 
typical transformed morphology induced by ras  and seen 
only after ~10-15 h (Stacy and Kung, 1984).  As a control 
for any nonspecific effects due to contaminating E. coli  pro- 
teins or the microinjection protocol itself, for example, Fig. 
1 d shows that a VaU4rho  protein containing an additional 
mutation (Thr37--*Ala37) in a region likely to be the effec- 
tor domain of ras-like proteins (Barbacid, 1987) is biologi- 
cally inactive after microinjection. 
It has been shown that the biological effects of a Vail2 mu- 
tation in ras can be mimicked by high level expression of the 
normal protein (McKay et al., 1986). Similarly, we find that 
injection of normal rho at >1.2 mg/ml gives the same mor- 
phological changes as injection of Vall4rho at 0.3  mg/ml 
(data not shown). Furthermore, if normal rho is first prein- 
cubated with the nonhydrolyzable GTP analogue, GTPq¢ S, 
before injection, its activity increases fourfold and it is now 
similar in potency to the Vall4rho protein (data not shown). 
These characteristic changes in morphology are not peculiar 
to Swiss 3T3 cells; we have observed similar effects in NIH- 
3T3, human fetal lung fibroblasts, and in NRK cells. 
To confirm further that the observed phenotypic changes 
are in fact due to the rho protein itself, we have microinjected 
a  eukaryotic  plasmid  expression  vector  containing  rho 
eDNA into the nuclei of subconfluent cells. After ,05 h the 
characteristic rho phenotype as  shown in Fig.  1 b  is ob- 
served. This experiment also indicates that the amino acid 
substitution used to stabilize the E.  coli-produced recom- 
binant rho (Phe--*Asn at codon 25) does not contribute to 
the observed effects. 
The changes in morphology induced by microinjection of 
rho protein are rapid; after 30 min most injected cells have 
taken on the  rho  phenotype.  Using  cycloheximide at  10 
#g/ml, we have shown that this effect does not require new 
protein synthesis. Furthermore, the changes were indepen- 
The Journal of Cell Biology, Volume 111,  1990  1002 Figure 1. Microinjection of recombinant rho proteins into Swiss-3T3 cells. Injection was into the cytoplasm of subconfluent cells grown 
on plastic petri dishes. The cells were visualized under phase-contrast optics. Cells were injected with the following: (a) buffer; (b) Vall4rho 
(0.5 mg/ml); (c) Vall2 ras (0.5 mg/ml); (d) Val14/Ala37 rho (0.5 mg/ml); and photographed after 1 h (a, b, and d) or 10 h (c). 
dent of the metabolic or growth state of the cells. Quiescent, 
growth factor-starved cells or actively growing cells both 
took on the rho phenotype 15-30 min after injection. 
Biological Effects of rho Ribosylation 
Fig. 2 a  shows the effects of microinjecting a pure prepara- 
tion of C3 transferase (30/~g/ml) into Swiss 3T3 cells. Cells 
round up completely and become refractile after ,x,l-2 h, 
though they still remain loosely attached to the substratum. 
The effects on morphology of activated rho and of C3 are, 
therefore, very different and distinctive. We find that concen- 
trations >3/zg/ml of C3 are required for efficient rounding 
up of cells. Uninjected cells are shown in Fig. 2 b. A similar 
effect has been observed by others but since rho is not the 
only substrate in cells it is not clear whether rounding up is 
a direct consequence of ribosylation of rho (Chardin et al., 
1989; Rubin et al.,  1988; Didsbury et al.,  1989). With the 
microinjection assay described above we are able to examine 
the effects of ribosylation on rho activity. First we incubated 
C3 transferase (0.3/xg/rnl) and Vall4rho (0.5 mg/ml) in vitro 
with NAD for 1 h.  The mixture was then injected directly 
into cells and ribosylated Vall4rho was found to be inacti- 
vated (data not shown). The experiment was next repeated 
using normal rho (also at 0.5 mg/ml) that had been prein- 
cubated with C3 transferase with or without NAD. In the ab- 
sence of NAD no ribosylation occurs and very little effect 
could be observed since the levels of normal rho and C3 in- 
jected are below their individual thresholds (Fig. 2 d). How- 
ever, Fig. 2 c shows that ribosylated normal rho had a similar 
effect on cells as high concentrations of C3, i.e., the injected 
cells rounded up. 
Biochemical Effects of rho Ribosylation 
To understand the different biological effects observed after 
injection of ribosylated normal and Vall4rho, the effect of 
ribosylation on the biochemical properties of the protein was 
determined.  Normal  and  Vall4rho  were  treated  with  C3 
transferase in vitro and the extent of ribosylation determined 
to  be  >40%  (see  Materials  and  Methods). The  guanine 
nucleotide exchange rates were then measured in high or low 
Mg  2÷  as  described previously (Hall  and  Self,  1986).  No 
effect of ribosylation was observed (data not shown). Fig. 3 
shows that ribosylation of normal rho also had no effect on 
either the intrinsic or the rhoGAP-stimulated GTPase activi- 
ties.  Ribosylation had no effect on the GTPase activity of 
Vall4rho (data not shown). 
Paterson et al. p21 rh° Induces Rapid Changes in Cell  Morphology  1003 Figure 2.  Microinjection of Swiss-3T3 cells with ribosylated rho 
proteins. Cells were photographed 2 h after injection. Cells in each 
quadrant of the petri dish were injected with the following: (a) C3 
transferase (30/~g/ml); (b) buffer; (c) a mixture of normal rho (0.5 
mg/ml) and C3 transferase (0.3/~g/ml) preincubated in the presence 
of NAD; and (d) as in c but preincubated in the absence of NAD. 
Effects of  a Ribosylation  Resistant rho Protein 
To test whether the rounded and refractile phenotype of cells 
treated with C3 transferase could be overcome with recom- 
binant rho, we have introduced an Asn~Ile mutation at the 
ribosylation site (codon 41) of normal and Vall4rho (Sekine 
et al.,  1989).  Fig. 4  shows that these proteins are, as ex- 
pected, resistant to ribosylation. Injection of  Vall4/fie41 rho 
at 0.5 mg/ml into cells has the same etfect as the Vall4rho 
protein showing that this amino acid substitution at codon 41 
does not impair biological activity. When cells were coin- 
jected with C3 transferase (at 30/zg/ml) and Vall4/Ile41 rho, 
cells took on the the phenotype (as shown in Fig.  1 b) and 
did not round up. 
Effects of Va114rho  on the Cytoskeleton 
It has been reported that C3 transferase when introduced into 
cells leads to a dissolution of the actin microfilament net- 
work but has  no effect on microtubules  (Chardin et al., 
1989). We wished to look at the effect  of Val14rho on subcel- 
lular structures. Fig. 5 shows the results of fluorescent stain- 
ing of Vall4rho-injected subconfluent Swiss 3T3  cells for 
three major cytoskeletal proteins. No obvious abnormalities 
could be discerned in the overall intracellular distribution of 
either actin or/3-tubulin with extensive microfdament (Fig. 
5, a and b) and microtuhule (Fig. 5, c and d) networks both 
clearly visible. Immunofluorescent labeling with antibodies 
against vimentin, however, revealed that in Vall4rho-inject- 
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Figure 3. Effect of ribosylation on the intrinsic 
and  rho  GAP-stimulated GTPase activity of 
normal the.  Control experiments (see Mate- 
rials and Methods) indicated that at least 40% 
of the protein was ribosylated. (o) Nondbosyl- 
ated protein in the absence of GAP; (n) non- 
ribosylated  protein in the presence of GAP; (e) 
ribosylated  protein in the absence of GAP; and 
(I)  ribosylated rho  in the presence of GAE 
The inset shows an expanded time course for 
the effects of ribosylation or the GAP activity. 
The Journal of Cell Biology,  Volume 111, 1990  1004 Figure 4.  Effect of Asn41~Ile41  mutation on ribosylation of rho. 
Proteins purified from E.  coil expression vectors were visualized 
by Western blot analysis using an anti-rho antibody and tested as 
substrates for C3 transferase using [32P]NAD followed by gel dec- 
trophoresis and autoradiography. (lane a) Normal rho with Ile41 
mutation; (lane b) normal rho; (lane c) Val14/Ile41 rho; and (lane 
d) Vall4rho. 
ed cells the intermediate filaments had collapsed into irregu- 
lar thick bundles within the cytoplasm (Fig.  5, e and f). 
A quite different picture emerged when contact-inhibited 
quiescent Swiss 3"1"3 cells were used. It can be seen (Fig. 6 
a) that, in contrast to subconfluent cells (Fig. 5 a), contact- 
inhibited cells do not possess well-defined actin filament net- 
works but instead show bright punctate actin staining. Injec- 
tion of Vall4rho into these cells (Fig. 6 b), however, rapidly 
(30 min) induced the reappearance of dense microfilament 
networks. Injection of Vall2ras or the biologically inactive 
Val14Ala37rho proteins had no effect. No collapse of inter- 
mediate filaments or changes in microtubule organization 
were induced in contact-inhibited cells injected with Val- 
14rho. 
Figure 5.  Fluorescence studies on Vall4rho-injected  subconfluent Swiss 3"1"3 cells. 3-4 h after injection cells were fixed and stained as 
described in Materials and Methods. Phase contrast and fluorescence are shown for uninjected (a, c, and e) and Vall4rho-injected  (b, 
d, and f) cells using TRITC-phalloidin (microfilaments) (a and b) or antitubulin (microtubules) (c and d) and antivimentin (intermediate 
filaments) (e and f) antibodies. 
Paterson et al. p21 rh° Induces Rapid Changes in Cell Morphology  1005 Figure 6. Fluorescence  studies on VAL14  injected contact-inhibited 
quiescent Swiss 3"1"3  cells. Cells were grown and left confluent for 
8 d before injection. 3-4 h after injection cells were fixed and 
stained as described in Materials and Methods. Phase contrast and 
fluorescence  are shown  for uninjected (a) and Vall4rho-injected (b) 
cells using TRIIC-phalloidin stain. 
Discussion 
The availability of full length recombinant rho protein has 
allowed us to examine its biological effects by using a micro- 
injection technique. Injection of constitutively activated rho 
protein (Vall4rho) into a variety of cell lines induces dra- 
matic changes in cell morphology commencing within 15 
min. The cell body contracts but finger-like processes re- 
main, resulting in a very distinctive phenotype (rho pheno- 
type). The rho phenotype is also induced after microinjec- 
tion of normal rho protein but higher concentrations are 
required. Prebinding of GTP'tS to normal rho, however, ac- 
tivates the protein and its effects are now similar to Vall4rho. 
The  changes  in  morphology  are  less  pronounced  when 
confluent cells are injected: the contacts between neighbor- 
ing cells seem to prevent the extreme changes in cell shape. 
It has been reported that treatment of cells with the ADP- 
ribosyltransferase C3 leads to a very different morphological 
change; cells round-up and this is accompanied by dissolu- 
tion of the actin microfilaments (Chardin et al., 1989). How- 
ever, since rho is not the only substrate for C3 and since the 
biochemical effect  of ribosylation ofrho is unknown, it is not 
clear if rounding up is due to rho ribosylation (Chardin et 
al., 1989; Didsbury et al., 1989). We show here that ribosy- 
lation of recombinant rho protein has no effect on its intrinsic 
biochemical properties  or on its interaction with the rho 
GTPase activating protein rho GAP. However,  ribosylation 
of Va114rho renders the protein biologically inactive. Since 
Vall4rho is expected to be constitutively in the active GTP- 
bound conformation (Garrett et al., 1989), we conclude that 
ribosylation blocks its  interaction with its target.  This  is 
analogous to mutations described in the effector region of ras 
(amino acid 30-40) which also have little effect on intrinsic 
biochemical properties but block its biological activity (Sigal 
et al.,  1986;  Willumsen et al.,  1986).  I~le0d the site for 
ribosylation in rho has been shown to be Kgn  41 (equivalent 
to codon 39 in ras), which is consistent with this being the 
region ofrho interacting with its target (Sekine et al., 1989). 
Interestingly, effector mutations in ras block interaction with 
ras GAP, leading to the speculation that ras GAP may be the 
target for regulation by ras (Cal6s et al., 1988; Adari et al., 
1988). Since ribosylation of  rho does not affect  its interaction 
with the 29-kD rho GAP (Fig. 3), we conclude that this pro- 
tein cannot be the sole target for regulation by rho, though 
its is still possible it is part of a larger regulatory complex. 
An unexpected result was obtained after injection of cells 
with ribosylated normal rho: cells rounded up in an analo- 
gous fashion to that observed after injecting C3 transferase. 
We can conclude from this experiment that the rounding up 
of cells induced by injection of C3 transferase can be totally 
accounted for by ribosylation and inactivation of endogenous 
rho. However, we also have to account for why injection of 
ribosylated Vall4rho has no effect on cells, whereas injection 
of ribosylated normal rho leads to rounding up; in both cases 
endogenous rho proteins are present. The best explanation 
we can offer is that injected ribosylated normal rho, which 
is in the GDP form, blocks endogenous rho proteins by com- 
peting for an upstream factor perhaps an exchange factor 
(Ohga et al., 1989) but cannot itself produce an effect since 
it is ribosylated; ribosylated Vall4rho cannot bind to this 
putative factor since it is permanently in the GTP form. 
Since ribosylated normal rho still interacts with rho GAP it 
will be maintained in the GDP form. 
We have obtained further confirmation that ribosylation of 
endogenous rho is responsible for C3-induced effects using 
a ribosylation resistant Vall4/Ile41 rho protein. When cells 
are coinjected with high levels of C3 transferase and Vail4/ 
Ile41  rho, the cells take on the distinctive Vall4rho pheno- 
type and do not round up. This indicates that the rounding 
up of cells and the dissolution of actin microfilarnents caused 
by C3 (Chardin et al.,  1989) can be reversed by exogenous 
activated rho. We have not, however,  been able to prevent 
C3-induced rounding up of cells using ribosylation resistant 
normal rho. It is possible that the normal cellular phenotype 
requires the activity of all three endogenous rho proteins, 
and we are only supplying rhoA; alternatively, it is possible 
that other non-rho C3 substrates, perhaps racl or 2, are re- 
quired in addition to rho for maintenance of normal cell mor- 
phology. 
The biochemical basis of the rho effects is not known. It 
has been shown that introducing C3 transferase into cells is 
followed by dissolution of actln filaments (Chardin et al., 
1989) without any major effect on microtubules. We find no 
obvious changes in actin filaments or microtubules after in- 
jection of Vall4rho into subeonfluent cells but we have found 
collapse of the intermediate filament (IF)  1  network as judged 
by immunofluorescence with antivimentin. Collapse of IFs 
1.  Abbreviation  used in  this paper:  IF,  intermediate filament. 
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cluding injection of antivimentin antibodies or stress shock 
CKlymkowsky, 1981; Thomas et al., 1982), but in both cases 
the collapse of the IF network was not accompanied by any 
changes in cell shape. It seems likely, therefore, that the col- 
lapse of IF shown in Fig. 5 e is a secondary effect and not 
the cause  of the Va114rho-induced shape  changes.  Inter- 
estingly, the morphological changes elicited by Val14rho in 
Swiss 3T3 cells can be mimicked by treatment with colchi- 
cine (H. E  Paterson,  unpublished data).  However, unlike 
Vall4rho-treated cells, colchicine treatment is accompanied 
by complete collapse of microtubules and IE For this reason 
we think that the observed morphological effects are not due 
to changes in the microtubule network. 
We have shown here that the inactivation of endogenous 
rho by C3 directly leads to rounding up of  cells and the disso- 
lution of microfilament network. An identical phenotype is 
observed after introducing another clostridium  ADP-ribo- 
syltransferase, C2, into cells, and C2 is known to ribosylate 
actin monomers preventing their polymerization (Aktories 
et al., 1986).  Although there are no obvious effects on actin 
microfilaments after introducing Vall4rho into subconfluent 
cells, the fluorescence studies would not rule out subtle effects 
on actin polymerization or cross-linking or on the attach- 
ment of microfilaments to the plasma membrane. We have 
obtained more direct experimental evidence that rho does in- 
deed affect actin filament organization, by looking at contact- 
inhibited quiescent cells. When Swiss 3T3 cells reach con- 
fluence and become quiescent, we have observed that they 
lose their actin filament network and show disorganized punc- 
tate actin staining (Fig. 6 a). If  Val14rho is injected into these 
cells, a dense actin filament network appears after ~30 min 
(Fig. 6 b).  Furthermore, the collapse of intermediate fila- 
ments observed in subconfluent cells injected with Vall4rho 
no longer occurs in these quiescent cells, consistent with the 
idea that the collapse seen in Fig. 5 fis a secondary effect. 
From the data presented in this paper, it seems clear that 
rho has a critical role in maintaining some aspect of the orga- 
nization of the cytoskeletal network that affects cell shape. 
A  more detailed biochemical analysis of the cytoskeleton 
and, in particular, actin microfilaments in Va114rho contain- 
ing cells is underway in an attempt to define further the func- 
tion of this protein. 
We would like to thank C. L  Marshall for helpful advice. 
The work was supported by the Cancer Research Campaign and the 
Medical Research Council. 
Received for publication  16 3anuary  1990 and in revised form  14 May 
1990. 
References 
Adari, H., D.  R. Lowy, B. M. Willumsen, C. J.  Der, and F. McCormick. 
1988.  GTPase activating protein (GAP)  interacts with the p21 ~  effector 
binding domain. Science (Wash.  DC). 240:518-521. 
Aktories, K., M. B~irmann, I. Ohishi, S, Isuyama, K. M. Jakobs, and E. Haber- 
mann.  1986.  Botulinum C2 toxin ADP-ribosylates actin. Nature (Lond.). 
322:390-392. 
Aktories, K., S. Roesener, U. Blaschke, and G. S. Chatwal. 1988. Botulinum 
ADP-ribosyltransferase C3. Fur. J. Biochem.  172:445-450. 
Aktories, K., U. Braun, S. R6sener, I. Just, and A. Hall. 1989. The rho gene 
product expressed in E. coli is a substrate of botulinum ADP-ribosyltrans- 
ferase C3. Biochem. Biophys.  Res.  Commun.  158:209-213. 
Barbacid,  M.  1987.  ras genes. Annu. Rev. Biochem.  56:779-827. 
Cal~s, C., J. F. Hancock, C. J. Marshall, and A. Hall. 1988. The cytoplasmic 
protein GAP is implicated as the target for regulation by the ras gene prod- 
uct. Nature (Lond.).  332:548-551. 
Chardin, P.  1988.  The ras superfamily proteins. Biochimie.  70:865-868. 
Chardin, P., P. Boquet, P. Madaule, M. R. Popoff,.E.J. Rubin, and D. M. 
Gill.  1989.  The mammalian G protein rho C is ADP-ribosylated by Clos- 
tridium botulinum exoenzyme C3 and affects actin microfilaments in vero 
cells. EMBO (Fur. Mol.  Biol.  Organ.) J.  8:1087-1092. 
Didsbury, L, R. F. Weber, G. M. Bokoch, T. Evans, andR. Snyderman. 1989. 
Rac, a novel ras-related family of proteins that are botulinum toxin substrates. 
J.  Biol.  Chem.  264:16378-16382. 
Garrett, M. D., A. J. Self, C. Van Oers, and A. Hall.  1989. Identification  of 
distinct cytoplasmic  targets for ras/R-ras and rho regulatory proteins. J. Biol. 
Chem.  264:10-13. 
Hall, A., and A. J. Self,  1986.  The effect of Mg  2+ on the guanine nucleotide 
exchange rate of p21 ~-ms. J.  Biol.  Chem.  261:10963-10965. 
Hancock, L  F., A. I. Magea, J. E. Childs, and C. J. Marshall. 1989. All ras 
proteins are polyisoprenylated but only some are palmitoylated. Cell.  57: 
1167-1177. 
Kitayama, H., Y. Sugimoto, T. Matsuzaki, Y. Ikawa, and M. Noda. 1989. A 
ras-related gene with transformation suppressor activity. Cell.  56:77-84. 
Klymkowsky, M. W.  1981. Intermediate filaments in 3T3 cells collapse after 
intracellular injection of a monoclonal anti-intermediate filament antibody. 
Nature (Lond.).  291:249-251. 
Lowe, D. G., D. J. Capon, E. Delwart, A. Y. Sakaguchi, and M. Noda. 1987. 
Structure of the human and mouse R-ras genes: novel genes closely related 
to ras proto-oncogenes. Cell.  48:137-146. 
Madaule, P., and R. Axel.  1985.  A novel ras-related gene family. Cell.  41: 
31-40. 
Madaule, P., R. Axel, and A. M. Myers. 1987. Characterization of two mem- 
bers of the rho gene family from the yeast Saccharomyces cerevisiae.  Proc. 
Natl.  Acad.  Sci.  84:779-783. 
McKay, I. A., C. J. Marshall, C. Cal6s, and A. Hall.  1986.  Transformation 
and stimulation of DNA synthesis in NIH-3T3 cells are a titratable  function 
of normal p21 ~;-'~ expression. EMBO (Eur. Mol.  Biol.  Organ.) J. 5:2617- 
2621. 
Morris, J. D. M., P. Price, A. C. Lloyd, A. J. Self, C. J. Marshall, and A. 
Hall. 1989. Scrape-loading of Swiss 3T3 cells with ras protein rapidly acti- 
vates protein kinase C in the absence of phosphoinositide hydrolysis. On- 
cogene.  4:27-31. 
Narumiya, S.,  A. Sekine, and M.  Fujiwara.  1988.  Suhstrate for Botulinum 
ADP-ribosyltransferase Gb, has an amino acid sequence homologous to a 
putative rho gene product. J.  Biol.  Chem.  263:17255-17257. 
Ohga, N., A. Kikuchi, T. Ueda, J. Yamamoto, and Y. Takai. 1989. Rabbit in- 
testine contains a protein that inhibits the dissociation of GDP from and the 
subsequent binding of GTP to rho B p20. Biochem.  Biophys.  Res. Commun. 
163:1523-1533. 
OIofsson, B., P. Chardin, N. Toudrot, A. Zahraoni, and A. Tavitian.  1988. 
Expression of the ras-related ralA rhol2 and rab genes in adult mouse tis- 
sues. Oncogene.  3:231-234. 
Pizon, V., P. Chardin, I. Lerosy, B. Olofsson, and A. Tavitian. 1988. Human 
cDNAs rapl and rap2 homologous  to the Drosophila gene Dras3 encode pro- 
teins closely related to ras in the effector  region. Oncogene.  3:201-204. 
Rubin, E. J., M.  D. Gill, P. BouqueL and M. R. Popoff.  1988.  Functional 
modification  of a 21 kilodalton  G protein when ADP-ribosylated by exoen- 
zyme C3 of Clostridium  botulinum. Mol.  Cell.  Biol.  8:418-426. 
Salmien, A., and P. J. Novick. 1987. a ras-like protein is required for a post- 
Golgi event in yeast secretion, Cell.  49:527-538. 
Segev, N., J. MulhoUand, and D. Botstein.  1988. The yeast GTP-binding YPT1 
protein and a mammalian counterpart are associated with the secretory ma- 
chinery. Cell.  52:915-924. 
Sekine, A,, M. Fujiwara, and S. Narumiya. 1989.  Asparagine residue in the 
rho gene product is the modification site for botulinum ADP-ribosyltrans- 
ferase, J. Biol.  Chem.  264:8602-8605. 
Stacy, D.  N., and H. F. Kung.  1984.  Transformation of NIH-3T3 cells by 
microinjection of Ha-ras p21  protein. Nature (Lond.).  310:508-511. 
Thomas, G. P., W. J. Welch, M. B. Mathews, andJ. R. Feramisco. 1982. Mo- 
lecular and cellular effects of  heat shock and related treatments of mammalian 
tissue culture cells. Cold Spring Harbor Syrup.  Quant.  Biol.  46:985-996. 
Willumsen, B. M., A. G. Papageorge, M. F. Kung, E. Bckesi, T. Robins, and 
D. R. Lowy. 1986. Mutational analysis ofa ras catalytic domain. Mol. Cell. 
Biol.  6:2646-2654. 
Yeramian, P., P, Chardin, P. Madaule, and A. Tavitian. 1987. Nucleotide se- 
quence of human rho eDNA clone 12. Nucleic Acids Res.  15:189. 
Zahraoui, A., N. Touchot, P. Chardin, and A. Tavitian. 1989. The human Rab 
genes encode a family of GTP binding proteins related to yeast YPT1 and 
SEC4 products involved in secretion. J.  Biol.  Chem.  264:12394-12401. 
Paterson et al. p21 rh° Induces Rapid Changes in Cell Morphology  1007 